Literature DB >> 27872507

Calculated Chemistry Parameters - do they need to be harmonised?

David Hughes1, James Cg Doery2, Kay Weng Choy3, Robert Flatman4.   

Abstract

In clinical chemistry, harmonisation of the testing process is a global initiative with the purpose of improving patient safety, allowing better integration of research data and enabling the use of national electronic heath records. In Australia, as in other countries, the initial focus has been on the harmonisation of the more commonly measured analytes. There are also a number of calculated parameters, derived from these measured analytes, which could also be considered for harmonisation. Calculated parameters that are reported by laboratories and used for clinical decision-making should undergo the same robust process of harmonisation as is the case for the measured analytes. Aspects that should be considered for harmonisation are: terminology, the formulae used and where possible the use of common reference intervals. To investigate pathways towards the harmonisation of calculated parameters, three commonly reported parameters are considered. Calculated osmolality, the anion gap and albumin-adjusted calcium are all derived from common analytes which have individually been considered for harmonisation. They present different methodological, measurement uncertainty and terminological hurdles to harmonisation and are likely to require different pathways and solutions.

Entities:  

Year:  2016        PMID: 27872507      PMCID: PMC5111245     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  15 in total

1.  Editorial: Selection of "recommended methods" for use in a clinical laboratory--some urgent considerations and a suggested approach.

Authors:  D O Rodgerson; N W Tietz
Journal:  Clin Chem       Date:  1975-07       Impact factor: 8.327

2.  The impact of calcium assay change on a local adjusted calcium equation.

Authors:  Sarah L Davies; Charlotte Hill; Lisa M Bailey; Andrew S Davison; Anna M Milan
Journal:  Ann Clin Biochem       Date:  2015-04-02       Impact factor: 2.057

3.  The case for common reference intervals.

Authors:  Graham R D Jones; Antony Barker; Jill Tate; Chen-Fee Lim; Ken Robertson
Journal:  Clin Biochem Rev       Date:  2004-05

4.  Gaps--anionic and osmolal.

Authors:  N Smithline; K D Gardner
Journal:  JAMA       Date:  1976-10-04       Impact factor: 56.272

5.  Harmonising adult and paediatric reference intervals in australia and new zealand: an evidence-based approach for establishing a first panel of chemistry analytes.

Authors:  Jillian R Tate; Ken A Sikaris; Graham Rd Jones; Tina Yen; Gus Koerbin; Julie Ryan; Maxine Reed; Janice Gill; George Koumantakis; Peter Hickman; Peter Graham
Journal:  Clin Biochem Rev       Date:  2014-11

6.  Evaluation of 36 formulas for calculating plasma osmolality.

Authors:  Andreas S Fazekas; Georg-Christian Funk; Daniela S Klobassa; Horst Rüther; Ingrid Ziegler; Rolf Zander; Hans-Jürgen Semmelrock
Journal:  Intensive Care Med       Date:  2012-10-19       Impact factor: 17.440

7.  It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurement.

Authors:  Paul Glendenning
Journal:  Ann Clin Biochem       Date:  2013-05       Impact factor: 2.057

8.  The adjusted serum calcium concept--a reappraisal.

Authors:  J P Ashby; D J Wright; M G Rinsler
Journal:  Ann Clin Biochem       Date:  1986-09       Impact factor: 2.057

Review 9.  Serum anion gap: its uses and limitations in clinical medicine.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Clin J Am Soc Nephrol       Date:  2006-12-06       Impact factor: 8.237

10.  Derivation and internal validation of an equation for albumin-adjusted calcium.

Authors:  Matthew T James; Jianguo Zhang; Andrew W Lyon; Brenda R Hemmelgarn
Journal:  BMC Clin Pathol       Date:  2008-11-27
View more
  1 in total

Review 1.  Hypercalcaemia - presentation and management .

Authors:  Jeremy J O Turner
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.